Weight & metabolic health

GLP-1 medicines at midlife: strong evidence, and the part about muscle and bone

The best-evidenced thing in this field, with a specific cost that matters more for women over 45 than for anyone else.

Well established · 8 min read

Controlled human trials, replicated, with outcomes that matter.

What is well established

Large randomised placebo-controlled trials show substantial, sustained weight reduction with GLP-1 receptor agonists and dual GLP-1/GIP agonists, alongside improved glycaemic control, and cardiovascular outcome benefit for some agents in defined populations. This is real, replicated, hard-outcome evidence — a different order of thing from most of what is marketed alongside it.

The part that matters more here

A meaningful share of the weight lost on these medicines is lean mass unless resistance training and adequate protein are deliberately maintained. For a woman already losing muscle and bone across the menopausal transition, that compounds an existing problem rather than being a neutral side effect. Rapid weight loss is also associated with bone mineral density decline. This does not make the medicines a bad idea; it makes the training non-negotiable.

Contraindications that apply here specifically

These are prescription medicines with real cautions: a personal or family history of medullary thyroid carcinoma or MEN 2, a history of pancreatitis, significant gastroparesis, and interactions with other glucose-lowering therapy. Critically for this audience: they are not for use in pregnancy, and because weight loss can restore ovulation in women who were not ovulating, contraception needs discussing before starting. Planned surgery and anaesthesia need discussing too, because of delayed gastric emptying.

Key points

  • Strong, replicated trial evidence for weight and glycaemic control.
  • Lean mass and bone loss make resistance training non-negotiable here.
  • Weight loss can restore ovulation — discuss contraception first.

AZZA Medical is not a medical provider and does not practice medicine. Medical services are provided exclusively by independently licensed physicians of our partner physician network and their affiliated professional entities.

Compounded drugs are not FDA-approved and have not been evaluated by FDA for safety or effectiveness.

This is not emergency care. AZZA Medical does not provide urgent or emergency medical services. If you are experiencing a medical emergency, call 911 or go to your nearest emergency room.

Reading is step one.

A panel is step two, and a physician decides what follows.

AZZA Medical is for adults 21 and over.